Amount$5M
Post-money valuation$200M
SeriesSeries F
AnnouncedOct 15, 2015
SectorLife Sciences
Mixed
A mixed round — some signals are off the norm.
Round size vs peers
Far below the typical Series F round — well under the median.
Syndicate size
Single investor — limited external validation.
Insider conviction
1 existing investor re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series F rounds (255)
Round size distribution1th pct
smaller Series F roundslarger
Post-money valuation1th pct
$200Mthis round: $200M$15B
